Spire Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
AI
Spire Wealth Management's BIO Position: Q1 2026 in Review
Spire Wealth Management sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2026, closing a stake of 35 shares — an estimated $10.6K sold.
Spire Wealth Management first reported a position in BIO in Q1 2021 and held it in 20 quarters. The position peaked at $26.9K in Q3 2023. 395 funds tracked by Wall St. Rank hold BIO as of Q1 2026.
- Spire Wealth Management reported no remaining Bio-Rad Laboratories Class A position as of Q1 2026 after selling out during the quarter.
- Spire Wealth Management sold 35 Bio-Rad Laboratories Class A shares in Q1 2026, an estimated $10.6K.
- Spire Wealth Management first reported a position in Bio-Rad Laboratories Class A in Q1 2021 and held it in 20 quarters.
- Spire Wealth Management's Bio-Rad Laboratories Class A position peaked at $26.9K in Q3 2023.
- 395 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2026.
Based on Spire Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.